digital currency 2023- Top snippets

The three major stock indexes opened lower, with the Shanghai Composite Index down 0.19%, the Shenzhen Component Index down 0.29% and the Growth Enterprise Market down 0.15%.The insurance sector fell by more than 8% in the short term, and the insurance sector fell by more than 8% in the short term. New China Life Insurance, China PICC, China Life Insurance and China Pacific Insurance followed suit.The Hang Seng Science and Technology Index rose to 1%, and the Hang Seng Index is now up 0.70%.

Robot concept stocks fell at the opening, Hanwang Technology fell, Hanwang Technology and Shandong Mining Machine fell, and Sanfeng Intelligent, Tuosida, Hanwei Technology, Shuanglin, Weichuang Electric, Fengli Intelligent and Wuzhou Xinchun fell more than 5%.Liquor stocks fluctuated and rebounded at the daily limit of Huangtai liquor industry, while liquor stocks fluctuated and rebounded at the daily limit of Huangtai liquor industry. Rock shares, gold seed wine, Yingjia tribute wine, Laobaigan wine, Jinhui wine, Shede wine industry and so on followed up.Institution: The Q3 revenue of the global semiconductor industry in 2024 reached US$ 158.2 billion, a year-on-year increase of 17%. Counterpoint Research, a market research organization, reported that the global semiconductor market picked up in the third quarter of 2024. Driven by the demand for artificial intelligence technology and the recovery of the memory market, the revenue of the global semiconductor industry in the third quarter reached US$ 158.2 billion, a year-on-year increase of 17%. The top 22 semiconductor suppliers in the world accounted for 73.1% of the market share, which was the same as the same period last year.

The insurance sector fell by more than 8% in the short term, and the insurance sector fell by more than 8% in the short term. New China Life Insurance, China PICC, China Life Insurance and China Pacific Insurance followed suit.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.South Korean prosecutors seized and searched the South Korean Special Forces Command. (CCTV News)